Abstract
Placental growth factor (PlGF) plays an important role in the inflammatory cascade associated with acute coronary syndromes and may be a prognostic biomarker in ACS patients. To examine this issue, researchers studied 547 placebo recipients with angiographically documented ACS from CAPTURE, a European angioplasty trial of abciximab, and a separate …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
